161 related articles for article (PubMed ID: 10442623)
1. The effectiveness of valacyclovir in preventing reactivation of herpes gladiatorum in wrestlers.
Anderson BJ
Clin J Sport Med; 1999 Apr; 9(2):86-90. PubMed ID: 10442623
[TBL] [Abstract][Full Text] [Related]
2. Valacyclovir to expedite the clearance of recurrent herpes gladiatorum.
Anderson BJ
Clin J Sport Med; 2005 Sep; 15(5):364-6. PubMed ID: 16162997
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic Valacyclovir to Prevent Outbreaks of Primary Herpes Gladiatorum at a 28-Day Wrestling Camp: A 10-Year Review.
Anderson BJ; McGuire DP; Reed M; Foster M; Ortiz D
Clin J Sport Med; 2016 Jul; 26(4):272-8. PubMed ID: 26540599
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic valacyclovir to prevent outbreaks of primary herpes gladiatorum at a 28-day wrestling camp.
Anderson BJ
Jpn J Infect Dis; 2006 Feb; 59(1):6-9. PubMed ID: 16495626
[TBL] [Abstract][Full Text] [Related]
5. The epidemiology and clinical analysis of several outbreaks of herpes gladiatorum.
Anderson BJ
Med Sci Sports Exerc; 2003 Nov; 35(11):1809-14. PubMed ID: 14600542
[TBL] [Abstract][Full Text] [Related]
6. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
Handsfield HH; Warren T; Werner M; Phillips JA
Sex Transm Dis; 2007 Jun; 34(6):339-43. PubMed ID: 17065847
[TBL] [Abstract][Full Text] [Related]
7. Managing herpes gladiatorum outbreaks in competitive wrestling: the 2007 Minnesota experience.
Anderson BJ
Curr Sports Med Rep; 2008; 7(6):323-7. PubMed ID: 19005353
[TBL] [Abstract][Full Text] [Related]
8. Long-term valacyclovir suppressive treatment after herpes simplex virus type 2 meningitis: a double-blind, randomized controlled trial.
Aurelius E; Franzen-Röhl E; Glimåker M; Akre O; Grillner L; Jorup-Rönström C; Studahl M;
Clin Infect Dis; 2012 May; 54(9):1304-13. PubMed ID: 22460966
[TBL] [Abstract][Full Text] [Related]
9. Use of valacyclovir for herpes simplex virus-1 (HSV-1) prophylaxis after facial resurfacing: A randomized clinical trial of dosing regimens.
Gilbert S; McBurney E
Dermatol Surg; 2000 Jan; 26(1):50-4. PubMed ID: 10632686
[TBL] [Abstract][Full Text] [Related]
10. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
Fife KH; Warren TJ; Justus SE; Heitman CK;
Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
[TBL] [Abstract][Full Text] [Related]
11. Single-day, patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: a randomized, double-blind, comparative trial.
Abudalu M; Tyring S; Koltun W; Bodsworth N; Hamed K
Clin Infect Dis; 2008 Sep; 47(5):651-8. PubMed ID: 18637755
[TBL] [Abstract][Full Text] [Related]
12. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group.
Tyring SK; Douglas JM; Corey L; Spruance SL; Esmann J
Arch Dermatol; 1998 Feb; 134(2):185-91. PubMed ID: 9487210
[TBL] [Abstract][Full Text] [Related]
13. Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation.
Dignani MC; Mykietiuk A; Michelet M; Intile D; Mammana L; Desmery P; Milone G; Pavlovsky S
Bone Marrow Transplant; 2002 Feb; 29(3):263-7. PubMed ID: 11859400
[TBL] [Abstract][Full Text] [Related]
14. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
[TBL] [Abstract][Full Text] [Related]
15. Valacyclovir versus acyclovir for HSV prophylaxisin neutropenic patients.
Warkentin DI; Epstein JB; Campbell LM; Yip JG; Cox VC; Ransier A; Barnett MJ; Marra F
Ann Pharmacother; 2002 Oct; 36(10):1525-31. PubMed ID: 12243600
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
Zuckerman RA; Lucchetti A; Whittington WL; Sanchez J; Coombs RW; Zuñiga R; Magaret AS; Wald A; Corey L; Celum C
J Infect Dis; 2007 Nov; 196(10):1500-8. PubMed ID: 18008230
[TBL] [Abstract][Full Text] [Related]
17. Herpes simplex virus 2 meningitis: a retrospective cohort study.
Miller S; Mateen FJ; Aksamit AJ
J Neurovirol; 2013 Apr; 19(2):166-71. PubMed ID: 23494382
[TBL] [Abstract][Full Text] [Related]
18. An outbreak of herpes gladiatorum at a high-school wrestling camp.
Belongia EA; Goodman JL; Holland EJ; Andres CW; Homann SR; Mahanti RL; Mizener MW; Erice A; Osterholm MT
N Engl J Med; 1991 Sep; 325(13):906-10. PubMed ID: 1652687
[TBL] [Abstract][Full Text] [Related]
19. Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies.
Baker D; Eisen D
Cutis; 2003 Mar; 71(3):239-42. PubMed ID: 12661753
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures.
Miller CS; Cunningham LL; Lindroth JE; Avdiushko SA
J Am Dent Assoc; 2004 Sep; 135(9):1311-8. PubMed ID: 15493396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
